IDPC urges European governments to take effective measures to reduce overcrowding and the risk of COVID-19 infection in prisons.

Release, TalkingDrugs and IDPC inventory existing decriminalisation models and provide insights into their implementation.

The IDPC membership share insights on progress and setbacks in drug policy reform in 45 countries.

IDPC and the Japan Advocacy Network for Drug Policy provide an overview of drug use in Japan, responses by public authorities and available support by civil society.

IDPC calls on governments of South-East Asia to consider measures to reduce the negative impacts of COVID-19 on people in prisons.

IDPC, WOLA, EQUIS and a host of community-led organisations and allies offer an overview of the many challenges faced by trans women in prison in Latin America.

PRI, Linklaters and IDPC find laws and sentencing guidelines often fail to consider the circumstances and role of women's involvement with drugs.

AIN, WOLA, Dejusticia and IDPC shed light on women growers' socioeconomic context, experiences of organising and participation in decision-making.

IDPC offers recommendations to the new UNODC Director related to a range of key concerns, including on UN system-wide coherence, human rights and health.

CELS, WOLA and IDPC highlight the negative impact of current drug policies on the rights of women.

IDPC and the Inspire Project analyse trends and factors mediating the imprisonment of women for drug offences, offering recommendations to reduce incarceration, improve prison conditions and facilitate post-release transitions.

HRI, IDPC, INPUD, NoBox Philippines and WCADP urge the Committee to shed light on rights abuses in the name of drug control in the Philippines.

IDPC and TNI reconstruct the long process that led to the development of a UN System Common Position on drug policy.

IDPC and GDPO unpick key issues raised by the 2019 World Drug Report through the lens of public health, including the expansion of regulated cannabis markets, the non-medical use of tramadol in Africa and challenges related to data-collection.

Government, civil society and community representatives discussed the state of play of debates in Vienna as well as developments in the field of human rights, development, public health and novel trends.

IDPC evaluates key wins and challenges from the 2019 event and offers recommendations on possible next steps for civil society advocacy.

This glossary offers translations in English, Spanish and French for terms commonly used in sectors related to drug policy and harm reduction.

IDPC highlights key network and Secretariat achievements between 2018-2019 and offers ideas to chart the course for the future.

The IDPC membership evaluate progress and setbacks in drug policy reform in 47 countries.

IDPC calls on the WHO and its governing bodies to engage in a more progressive and systematic way in various aspects of global drug policy.